Surgical Science Sweden
136.9
SEK
+13.05 %
SUS
First North Stockholm
Medical Equipment & Services
Health Care
17 following
surgicalscience.com
Surgical Science Sweden is a medical technology company. The company develops VR simulators in surgery. The simulators consist of both hardware and software used in training and personal development by surgeons. The hardware simulates various surgical procedures, with mainly use in peephole surgery and endoscopy. The vision is to strengthen the competence in surgery and create conditions for better treatments. The company is headquartered in Gothenburg.
Revenue
882.85M
EBIT %
21.42 %
P/E
29.83
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
SUS
Daily low / high price
120.7 / 140
SEK
Market cap
6.99B SEK
Turnover
63.47M SEK
Volume
478K
Latest videos
Financial calendar
Interim report
2024-11-14
Annual report
2025-02-19
Interim report
2025-05-14
Interim report
2025-08-21
Interim report
2025-11-13
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Marknadspotential AB | 14.0 % | 14.0 % |
Roland Bengtsson | 11.7 % | 11.7 % |
Handelsbanken Fonder | 7.6 % | 7.6 % |
Capital Group | 6.4 % | 6.4 % |
Fjärde AP-Fonden | 6.0 % | 6.0 % |
Kirkbi Invest A/S | 5.8 % | 5.8 % |
TIN Fonder | 5.2 % | 5.2 % |
Swedbank Robur Fonder | 4.0 % | 4.0 % |
Andra AP-fonden | 3.2 % | 3.2 % |
Amundi | 2.3 % | 2.3 % |
ShowingAll content types
Delårsrapport januari - september 2024: VALUTANEUTRAL FÖRSÄLJNINGSÖKNING 12%
Interim report January – September 2024: 12% CURRENCY-NEUTRAL INCREASE IN SALES
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools